Flexible Electronics News

PCAS, NOVACAP Form SEQENS

Specialty ingredients and pharmaceutical synthesis leader creates new name.

Author Image

By: DAVID SAVASTANO

Editor, Ink World Magazine

PCAS and all NOVACAP subsidiaries have unified their names into a new one and become SEQENS.   SEQENS is an integrated global leader in specialty ingredients and pharmaceutical synthesis, operating 24 manufacturing plants and three R&D centers in Europe, North America and Asia with 3,200 employees. More than 300 scientists, engineers and experts develop tailor-made solutions for customers and ensure that products are successfully transferred into production.   SEQENS refers to the compan...

Continue reading this story and get 24/7 access to Ink World magazine for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Ink World magazine Newsletters